Jindao Wu

Title: Jindao Wu: Innovator in Adipose Tissue-Targeting Drug Delivery

Introduction

Jindao Wu is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of drug delivery systems, particularly in targeting adipose tissue for obesity treatment. His innovative approach combines biocompatibility with effective drug delivery mechanisms.

Latest Patents

Jindao Wu holds a patent for an "Adipose tissue-targeting polypeptide-verbascoside-nanogold particle derivative, preparation method and application thereof." This patent outlines a method for preparing a derivative that enhances drug delivery to adipocytes, thereby improving the efficacy of anti-obesity drugs. The method involves activating a carboxyl group of a cysteine residue, esterifying it with sodium phenolate, and reacting it with PEG-modified nanogold particles. The resulting derivative demonstrates good biocompatibility and significantly enhances the targeted anti-obesity activity of the drug.

Career Highlights

Wu has worked at notable institutions, including the Affiliated Stomatological Hospital of Nanjing Medical University and Nanjing Medical University. His work in these institutions has allowed him to collaborate with other experts in the field and further his research in innovative drug delivery systems.

Collaborations

Some of his notable coworkers include Yi Yuan and Yaqin Zhang. Their collaborative efforts have contributed to the advancement of research in adipose tissue-targeting therapies.

Conclusion

Jindao Wu's innovative work in developing adipose tissue-targeting drug delivery systems showcases his commitment to addressing obesity through advanced biotechnological solutions. His contributions are paving the way for more effective treatments in the field of medicine.